Medication info

Olmesartan Medoxomil Tablets 10 mg (Olmesartan Medoxomil)

Prescription medicationTabletOralExpired
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White, round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201906478 · Approved 2019.09.17

This product's status changed to Expired on 2024.09.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), treatment should be started at a low dose with close monitoring of their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients 65 years of age or older. No overall differences in efficacy and safety were observed between elderly and younger patients; however, increased sensitivity in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Children> The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is hypertension that occurs without a specific cause, and it is used to lower blood pressure and prevent cardiovascular complications.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), treatment should be started at a low dose with close monitoring of their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients 65 years of age or older. No overall differences in efficacy and safety were observed between elderly and younger patients; however, increased sensitivity in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Children> The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to any ingredients in this medication, pregnant or nursing women, patients undergoing renal dialysis, patients with severe liver dysfunction, patients with biliary obstruction, etc., should not take this medication. Patients with insufficient blood volume or sodium may experience hypotension at the initial dosage, so caution is necessary, and appropriate treatment should be received if symptoms occur. This medication may affect kidney function, so patients with impaired kidney function should have their kidney status checked through regular blood tests. There is a risk of hyperkalemia; therefore, patients with heart disease or kidney disease in particular should frequently check their serum potassium levels. Patients with aortic or mitral stenosis, obstructive or hypertrophic cardiomyopathy should take this medication with special caution. This medication may cause dizziness; therefore, it is advisable to avoid dangerous tasks such as working at heights or driving vehicles. This medication generally has few side effects and good tolerability; however, symptoms such as dizziness, headache, dyspepsia, muscle pain, and skin rash may occur. Taking this medication during pregnancy increases the risk of fetal kidney dysfunction, oligohydramnios, and craniofacial malformation; therefore, women planning to conceive or those who are pregnant should consult with healthcare providers. Nursing mothers should be aware that this medication may be transmitted through breast milk and could cause side effects in infants; therefore, they should either stop nursing or discontinue the medication. Safety and effectiveness in children have not yet been established, so it should be administered to children with caution. Elderly patients may have increased blood concentrations of the drug; therefore, caution is required when administering this medication. Interactions may occur if this medication is taken with potassium-sparing diuretics, potassium supplements, lithium, or non-steroidal anti-inflammatory drugs, so healthcare providers should be informed. In cases of overdose, hypotension and palpitations may occur, and appropriate treatment should be provided depending on the symptoms. This medication has not been reported to be carcinogenic or genotoxic even with long-term use; however, rare side effects such as liver dysfunction or angioedema may occur; therefore, regular monitoring is necessary.

Side effects

dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be maintained between 1°C and 25°C at room temperature to preserve the drug's efficacy.

Appearance and packaging

Appearance

White, round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.